CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale EVP Research & Development sold 3,500 shares at $75.46 ($264,110)
- 4 Planned sale Director sold 5,000 shares at $71.48 ($357,400)
- 4 Planned sale EVP, Chief Commercial Officer sold 10,000 shares at $70.24 ($702,400)
- 4 Planned sale President & CEO sold 7,500 shares at $70.24 ($526,800)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $75.82 ($265,370)
- 4 Planned sale President & CEO sold 7,500 shares at $76.76 ($575,700)
- 4 Planned sale EVP, Chief Commercial Officer sold 14,000 shares at $79.88 ($1,118,320)
- 4 Planned sale President & CEO sold 7,500 shares at $80.87 ($606,525)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $80.59 ($282,065)
- 4 Grant or award Director acquired 75 shares (grant or award)
- 4 Grant or award Director acquired 75 shares (grant or award)
- 4 Grant or award Director acquired 151 shares (grant or award)
- 4 Grant or award Director acquired 272 shares (grant or award)
- 4 Grant or award Director acquired 151 shares (grant or award)
- 4 Grant or award Director acquired 151 shares (grant or award)
- 4 Planned sale President & CEO sold 7,500 shares at $82.02 ($615,150)
- 4 Planned sale EVP Research & Development sold 3,500 shares at $86.62 ($303,170)
- 4 Planned sale President & CEO sold 7,500 shares at $84.92 ($636,900)
- 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $85.80 ($1,287,000)
- 4 Planned sale EVP, Chief Financial Officer sold 1,112 shares at $87.79 ($97,622)
Page 2 of 70 · 1,399 filings